CTRP1 decreases ABCA1 expression and promotes lipid accumulation through the miR-424-5p/FoxO1 pathway in THP-1

Zi-Zhen Zhang1, Jiao-Jiao Chen2, Wen-Yi Deng2

  • 1School of Medicine, Hunan Polytechnic of Environment and Biology, Hengyang, Hunan, China.

Insights

C1q tumor necrosis factor-related protein 1 (CTRP1) worsens atherosclerosis by reducing cholesterol removal from macrophages. CTRP1 lowers ABCA1 transporter expression via a miR-424-5p/FoxO1 pathway, promoting foam cell formation.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Cell Biology

Background:

  • ATP binding cassette transporter A1 (ABCA1) is crucial for cholesterol efflux from macrophages, and its dysfunction contributes to atherosclerosis.
  • C1q tumor necrosis factor-related protein 1 (CTRP1), an adiponectin paralog, is implicated in promoting atherosclerosis through inflammation.

Purpose of the Study:

  • To investigate the role of CTRP1 in regulating ABCA1 expression and macrophage lipid accumulation.
  • To elucidate the molecular mechanisms underlying CTRP1's effects on cholesterol homeostasis.

Main Methods:

  • Utilized THP-1 macrophage-derived foam cells to assess CTRP1's impact on ABCA1 expression and cholesterol efflux.
  • Investigated the involvement of microRNA-424-5p (miR-424-5p) and Forkhead box O1 (FoxO1) in the CTRP1 signaling pathway.

Main Results:

  • CTRP1 significantly downregulated ABCA1 expression and inhibited cholesterol efflux to apoA-I in macrophages.
  • CTRP1 promoted lipid accumulation in macrophage-derived foam cells.
  • CTRP1 was found to decrease miR-424-5p levels, leading to increased nuclear FoxO1 expression and subsequent ABCA1 downregulation.

Conclusions:

  • CTRP1 restrains cholesterol efflux and promotes macrophage lipid accumulation by inhibiting the miR-424-5p/FoxO1/ABCA1 signaling pathway.
  • These findings offer novel mechanistic insights into CTRP1's proatherosclerotic actions.